Completed NA INTERVENTIONAL 1-arm NCT04788758

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Feasibility of Implementation and Assessment of Geriatric Assessment Screening Tool in Outpatient Oncology Clinic

Sponsor: Thomas Jefferson University

Conditions Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Interventions Educational Intervention Questionnaire Administration Referral Screening Questionnaire Administration

Updated 6 times since 2021 Last updated: Apr 28, 2025 Started: Jan 29, 2020 Primary completion: May 25, 2022 Completion: May 25, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04788758, this NA trial focuses on Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm and remains completed. Sponsored by Thomas Jefferson University, it has been updated 6 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

May 2025 — Present [monthly]

Completed NA
Sep 2024 — May 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed · Phase: PHASE2 → NA
Oct 2021 — Sep 2022 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Apr 2021 — Oct 2021 [monthly]

Recruiting PHASE2

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Thomas Jefferson University

Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States